Michael Bogenschutz

Summary

Affiliation: University of New Mexico
Country: USA

Publications

  1. ncbi Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
    Michael P Bogenschutz
    University of New Mexico Health Sciences Center, Department of Psychiatry Center for Psychiatric Research, University of New Mexico, Albuquerque, NM 87131 0001, USA
    Drug Test Anal 4:543-55. 2012
  2. ncbi Pharmacologic treatments for women with addictions
    Michael P Bogenschutz
    Department of Psychiatry, University of New Mexico School of Medicine, 2400 Tucker NE, Albuquerque, NM 87131, USA
    Obstet Gynecol Clin North Am 30:523-44. 2003
  3. ncbi Olanzapine versus placebo in the treatment of borderline personality disorder
    Michael P Bogenschutz
    Department of Psychiatry, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
    J Clin Psychiatry 65:104-9. 2004
  4. ncbi Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED)
    Michael P Bogenschutz
    Department of Psychiatry, Health Sciences Center, University of New Mexico, Albuquerque, 87131, USA
    Am J Drug Alcohol Abuse 37:417-25. 2011
  5. ncbi Specialized 12-step programs and 12-step facilitation for the dually diagnosed
    Michael P Bogenschutz
    Department of Psychiatry, University of New Mexico Health Sciences Center, 2400 Tucker NE, Albuquerque, NM 87131, USA
    Community Ment Health J 41:7-20. 2005
  6. ncbi The role of twelve-step approaches in dual diagnosis treatment and recovery
    Michael P Bogenschutz
    Department of Psychiatry, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, USA
    Am J Addict 15:50-60. 2006
  7. ncbi Effects of alcoholism typology on response to naltrexone in the COMBINE study
    Michael P Bogenschutz
    University of New Mexico Health Sciences Center, Department of Psychiatry and University of New Mexico Center on Alcoholism, Substance Abuse, and Addictions, Albuquerque, New Mexico
    Alcohol Clin Exp Res 33:10-8. 2009
  8. ncbi Examining the effects of alcoholism typology and AA attendance on self-efficacy as a mechanism of change
    Michael P Bogenschutz
    Center on Alcoholism, Substance Abuse and Addictions CASAA, University of New Mexico, 2650 Yale SE, Albuquerque, New Mexico 87106, USA
    J Stud Alcohol 67:562-7. 2006
  9. ncbi 12-step approaches for the dually diagnosed: mechanisms of change
    Michael P Bogenschutz
    UNM Health Sciences Center, Department of Psychiatry and Center on Alcoholism, Substance Abuse, and Addictions, University of New Mexico, Albuquerque, NM 87131, USA
    Alcohol Clin Exp Res 31:64s-66s. 2007
  10. ncbi Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatients
    Juan R Bustillo
    Department of Psychiatry, Research Division, 2400 Tucker NE, University of New Mexico, Albuquerque, NM 87131, USA
    Neuropsychopharmacology 28:527-9. 2003

Research Grants

  1. 12-Step Facilitation for the Dually Diagnosed
    Michael Bogenschutz; Fiscal Year: 2009
  2. Clinical Trial Network: Southwest Node
    Michael Bogenschutz; Fiscal Year: 2007
  3. Clinical Trial Network: Southwest Node
    Michael Bogenschutz; Fiscal Year: 2007
  4. A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders
    Michael Bogenschutz; Fiscal Year: 2007
  5. Clinical Trials Network: New Mexico Node
    Michael Bogenschutz; Fiscal Year: 2006

Detail Information

Publications19

  1. ncbi Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
    Michael P Bogenschutz
    University of New Mexico Health Sciences Center, Department of Psychiatry Center for Psychiatric Research, University of New Mexico, Albuquerque, NM 87131 0001, USA
    Drug Test Anal 4:543-55. 2012
    ..We conclude that existing evidence provides a convincing rationale for further research on the effects of classic hallucinogens in the treatment of addiction...
  2. ncbi Pharmacologic treatments for women with addictions
    Michael P Bogenschutz
    Department of Psychiatry, University of New Mexico School of Medicine, 2400 Tucker NE, Albuquerque, NM 87131, USA
    Obstet Gynecol Clin North Am 30:523-44. 2003
    ..The obstetrician gynecologist must determine the scope of his or her own practice in this area (ie, when to treat and when to refer) based on interest, training and experience, and available resources...
  3. ncbi Olanzapine versus placebo in the treatment of borderline personality disorder
    Michael P Bogenschutz
    Department of Psychiatry, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
    J Clin Psychiatry 65:104-9. 2004
    ..Here, we report the results of a double-blind, placebo-controlled study of olanzapine as a treatment for BPD...
  4. ncbi Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED)
    Michael P Bogenschutz
    Department of Psychiatry, Health Sciences Center, University of New Mexico, Albuquerque, 87131, USA
    Am J Drug Alcohol Abuse 37:417-25. 2011
    ....
  5. ncbi Specialized 12-step programs and 12-step facilitation for the dually diagnosed
    Michael P Bogenschutz
    Department of Psychiatry, University of New Mexico Health Sciences Center, 2400 Tucker NE, Albuquerque, NM 87131, USA
    Community Ment Health J 41:7-20. 2005
    ..Larger and longer-term studies are needed to assess the efficacy of modified TSF for DDI relative to other treatments, and to determine what forms of TSF are most effective in this population...
  6. ncbi The role of twelve-step approaches in dual diagnosis treatment and recovery
    Michael P Bogenschutz
    Department of Psychiatry, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131, USA
    Am J Addict 15:50-60. 2006
    ..More work is needed to determine what kinds of twelve-step treatments and programs are effective for various types of patients and elucidate the mechanisms by which these approaches facilitate recovery...
  7. ncbi Effects of alcoholism typology on response to naltrexone in the COMBINE study
    Michael P Bogenschutz
    University of New Mexico Health Sciences Center, Department of Psychiatry and University of New Mexico Center on Alcoholism, Substance Abuse, and Addictions, Albuquerque, New Mexico
    Alcohol Clin Exp Res 33:10-8. 2009
    ..g., conduct disorder), and greater frequency of comorbid psychiatric and substance use disorders...
  8. ncbi Examining the effects of alcoholism typology and AA attendance on self-efficacy as a mechanism of change
    Michael P Bogenschutz
    Center on Alcoholism, Substance Abuse and Addictions CASAA, University of New Mexico, 2650 Yale SE, Albuquerque, New Mexico 87106, USA
    J Stud Alcohol 67:562-7. 2006
    ..The purpose of this study was to evaluate the mediational role of self-efficacy on changes in drinking associated with Alcoholics Anonymous (AA) attendance in Type-A and Type-B alcoholics...
  9. ncbi 12-step approaches for the dually diagnosed: mechanisms of change
    Michael P Bogenschutz
    UNM Health Sciences Center, Department of Psychiatry and Center on Alcoholism, Substance Abuse, and Addictions, University of New Mexico, Albuquerque, NM 87131, USA
    Alcohol Clin Exp Res 31:64s-66s. 2007
    ..Existing data indicate that 12-step program involvement is associated with improved outcomes in the dually diagnosed, but there are questions concerning the magnitude and mechanisms of this effect in various dually diagnosed populations...
  10. ncbi Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatients
    Juan R Bustillo
    Department of Psychiatry, Research Division, 2400 Tucker NE, University of New Mexico, Albuquerque, NM 87131, USA
    Neuropsychopharmacology 28:527-9. 2003
    ..Serotonin reuptake inhibitors are probably not a practical option to counteract weight gain induced by atypical antipsychotics. Atypical-induced weight gain may result from mechanisms other than 5HT reuptake blockade...
  11. ncbi Spirituality and addiction
    William R Miller
    Center on Alcoholism, Substance Abuse and Addictions and the Department of Psychology, University of New Mexico, Albuquerque 87131-0001, USA
    South Med J 100:433-6. 2007
  12. ncbi Is alcoholism typology a predictor of both Alcoholics Anonymous affiliation and disaffiliation after treatment?
    J Scott Tonigan
    Department of Psychology, Center on Alcoholism, Substance Abuse, and Addictions CASAA, University of New Mexico, 2650 Yale Southeast, Albuquerque, NM 87106, USA
    J Subst Abuse Treat 30:323-30. 2006
    ..Findings also indicate that, among treatment-seeking problem drinkers, AA dropout and disaffiliation are distinct, albeit correlated, constructs that require future investigation...
  13. ncbi Pharmacotherapy for pregnant women with addictions
    William F Rayburn
    Department of Obstetrics and Gynecology, University of New Mexico, MSC 10 5580, Albuquerque, NM 87131 0001, USA
    Am J Obstet Gynecol 191:1885-97. 2004
    ..The purpose of this systematic review was to summarize current experience that pertains to pharmacotherapy for pregnant women with specific chemical addictions...
  14. ncbi Perturbation of the glutamate-glutamine system in alcohol dependence and remission
    Robert Thoma
    MIND Research Network, Albuquerque, NM, USA
    Neuropsychopharmacology 36:1359-65. 2011
    ..The absence of differences in mean Glu and Gln between the AUD and AUD-R groups suggests that altered Glu-Gln metabolism may either predate the onset of abuse or persist during prolonged abstinence...
  15. ncbi Adolescent substance abuse: the effects of alcohol and marijuana on neuropsychological performance
    Robert J Thoma
    Department of Psychiatry, University of New Mexico, Albuquerque, 87131, USA
    Alcohol Clin Exp Res 35:39-46. 2011
    ....
  16. ncbi Pharmacological research on addictions: a framework for ethical and policy considerations
    Cynthia Geppert
    New Mexico Veterans Affairs Health Care System, Albuquerque, NM, USA
    J Psychoactive Drugs 41:49-60. 2009
    ..An evidence-based analysis suggests that sound pharmacological research in SUD can safeguard the welfare of research participants while collecting valuable scientific data and benefiting society...
  17. ncbi Ethics in substance use disorder treatment
    Cynthia M A Geppert
    New Mexico Veterans Affairs Health Care System, 1510 San Pedro Drive SE, Albuquerque, NM 87108, USA
    Psychiatr Clin North Am 32:283-97. 2009
    ....
  18. ncbi Development of a bibliography on religion, spirituality and addictions
    Cynthia Geppert
    New Mexico Veterans Affairs Health Care System, Department of Psychiatry, University of New Mexico School of Medicine, Religious Studies Program, University of New Mexico, USA
    Drug Alcohol Rev 26:389-95. 2007
    ..The aim of this study was to develop a comprehensive annotated public-domain bibliography of the literature on spirituality and addictions to facilitate future research and scholarship...
  19. ncbi Response: anticipating new medications
    Michael P Bogenschutz
    Addict Sci Clin Pract 4:36-8. 2008

Research Grants12

  1. 12-Step Facilitation for the Dually Diagnosed
    Michael Bogenschutz; Fiscal Year: 2009
    ..abstract_text> ..
  2. Clinical Trial Network: Southwest Node
    Michael Bogenschutz; Fiscal Year: 2007
    ..abstract_text> ..
  3. Clinical Trial Network: Southwest Node
    Michael Bogenschutz; Fiscal Year: 2007
    ....
  4. A Program of Research and Mentorship on Alcoholism and Co-occuring Disorders
    Michael Bogenschutz; Fiscal Year: 2007
    ..There is a need for better understanding and more effective treatments for these conditions. This grant supports the development of new research approaches and new researchers in this important field. ..
  5. Clinical Trials Network: New Mexico Node
    Michael Bogenschutz; Fiscal Year: 2006
    ..abstract_text> ..